Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jennifer Savage is active.

Publication


Featured researches published by Jennifer Savage.


American Journal of Physiology-cell Physiology | 2008

Small mouse cholangiocytes proliferate in response to H1 histamine receptor stimulation by activation of the IP3/CaMK I/CREB pathway

Heather Francis; Shannon Glaser; Sharon DeMorrow; Eugenio Gaudio; Yoshiyuki Ueno; Julie Venter; David E. Dostal; Paolo Onori; Antonio Franchitto; Marco Marzioni; Shelley Vaculin; Bradley Vaculin; Khurshed A. Katki; Monique Stutes; Jennifer Savage; Gianfranco Alpini

Cholangiopathies are characterized by the heterogeneous proliferation of different-sized cholangiocytes. Large cholangiocytes proliferate by a cAMP-dependent mechanism. The function of small cholangiocytes may depend on the activation of inositol trisphosphate (IP(3))/Ca(2+)-dependent signaling pathways; however, data supporting this speculation are lacking. Four histamine receptors exist (HRH1, HRH2, HRH3, and HRH4). In several cells: 1) activation of HRH1 increases intracellular Ca(2+) concentration levels; and 2) increased [Ca(2+)](i) levels are coupled with calmodulin-dependent stimulation of calmodulin-dependent protein kinase (CaMK) and activation of cAMP-response element binding protein (CREB). HRH1 agonists modulate small cholangiocyte proliferation by activation of IP(3)/Ca(2+)-dependent CaMK/CREB. We evaluated HRH1 expression in cholangiocytes. Small and large cholangiocytes were stimulated with histamine trifluoromethyl toluidide (HTMT dimaleate; HRH1 agonist) for 24-48 h with/without terfenadine, BAPTA/AM, or W7 before measuring proliferation. Expression of CaMK I, II, and IV was evaluated in small and large cholangiocytes. We measured IP(3), Ca(2+) and cAMP levels, phosphorylation of CaMK I, and activation of CREB (in the absence/presence of W7) in small cholangiocytes treated with HTMT dimaleate. CaMK I knockdown was performed in small cholangiocytes stimulated with HTMT dimaleate before measurement of proliferation and CREB activity. Small and large cholangiocytes express HRH1, CaMK I, and CaMK II. Small (but not large) cholangiocytes proliferate in response to HTMT dimaleate and are blocked by terfenadine (HRH1 antagonist), BAPTA/AM, and W7. In small cholangiocytes, HTMT dimaleate increased IP(3)/Ca(2+) levels, CaMK I phosphorylation, and CREB activity. Gene knockdown of CaMK I ablated the effects of HTMT dimaleate on small cholangiocyte proliferation and CREB activation. The IP(3)/Ca(2+)/CaMK I/CREB pathway is important in the regulation of small cholangiocyte function.


Laboratory Investigation | 2009

Morphological and functional heterogeneity of the mouse intrahepatic biliary epithelium

Shannon Glaser; Eugenio Gaudio; Arundhati Rao; Lisa M. Pierce; Paolo Onori; Antonio Franchitto; Heather Francis; David E. Dostal; Julie Venter; Sharon DeMorrow; Romina Mancinelli; Guido Carpino; Domenico Alvaro; Shelley Kopriva; Jennifer Savage; Gianfranco Alpini

Rat and human biliary epithelium is morphologically and functionally heterogeneous. As no information exists on the heterogeneity of the murine intrahepatic biliary epithelium, and with increased usage of transgenic mouse models to study liver disease pathogenesis, we sought to evaluate the morphological, secretory, and proliferative phenotypes of small and large bile ducts and purified cholangiocytes in normal and cholestatic mouse models. For morphometry, normal and bile duct ligation (BDL) mouse livers (C57/BL6) were dissected into blocks of 2–4 μm2, embedded in paraffin, sectioned, and stained with hematoxylin and eosin. Sizes of bile ducts and cholangiocytes were evaluated by using SigmaScan to measure the diameters of bile ducts and cholangiocytes. In small and large normal and BDL cholangiocytes, we evaluated the expression of cholangiocyte-specific markers, keratin-19 (KRT19), secretin receptor (SR), cystic fibrosis transmembrane conductance regulator (CFTR), and chloride bicarbonate anion exchanger 2 (Cl−/HCO3− AE2) by immunofluorescence and western blot; and intracellular cyclic adenosine 3′,5′-monophosphate (cAMP) levels and chloride efflux in response to secretin (100 nM). To evaluate cholangiocyte proliferative responses after BDL, small and large cholangiocytes were isolated from BDL mice. The proliferation status was determined by analysis of the cell cycle by fluorescence-activated cell sorting, and bile duct mass was determined by the number of KRT19-positive bile ducts in liver sections. In situ morphometry established that the biliary epithelium of mice is morphologically heterogeneous, with smaller cholangiocytes lining smaller bile ducts and larger cholangiocytes lining larger ducts. Both small and large cholangiocytes express KRT19 and only large cholangiocytes from normal and BDL mice express SR, CFTR, and Cl−/HCO3− exchanger and respond to secretin with increased cAMP levels and chloride efflux. Following BDL, only large mouse cholangiocytes proliferate. We conclude that similar to rats, mouse intrahepatic biliary epithelium is morphologically and functionally heterogeneous. The mouse is therefore a suitable model for defining the heterogeneity of the biliary tree.


American Journal of Physiology-gastrointestinal and Liver Physiology | 2009

Follicle-stimulating hormone increases cholangiocyte proliferation by an autocrine mechanism via cAMP-dependent phosphorylation of ERK1/2 and Elk-1

Romina Mancinelli; Paolo Onori; Eugenio Gaudio; Sharon DeMorrow; Antonio Franchitto; Heather Francis; Shannon Glaser; Guido Carpino; Julie Venter; Domenico Alvaro; Shelley Kopriva; Mellanie White; Ashley N. Kossie; Jennifer Savage; Gianfranco Alpini

Sex hormones regulate cholangiocyte hyperplasia in bile duct-ligated (BDL) rats. We studied whether follicle-stimulating hormone (FSH) regulates cholangiocyte proliferation. FSH receptor (FSHR) and FSH expression was evaluated in liver sections, purified cholangiocytes, and cholangiocyte cultures (NRICC). In vivo, normal female and male rats were treated with FSH or immediately after BDL with antide (a gonadotropin-releasing hormone antagonist blocking FSH secretion) or a neutralizing FSH antibody for 1 wk. We evaluated 1) cholangiocyte proliferation in sections and cholangiocytes and 2) changes in secretin-stimulated cAMP (functional index of cholangiocyte growth) levels, and ERK1/2 and Elk-1 phosphorylation. NRICC were stimulated with FSH before evaluation of proliferation, cAMP/IP(3) levels, and ERK1/2 and Elk-1 phosphorylation. To determine whether FSH regulates cholangiocyte proliferation by an autocrine mechanism, we evaluated the effects of 1) cholangiocyte supernatant (containing FSH) on NRICC proliferation and 2) FSH silencing in NRICC before measuring proliferation and ERK1/2 and Elk-1 phosphorylation. Cholangiocytes and NRICC express FSHR and FSH and secrete FSH. In vivo administration of FSH to normal rats increased, whereas administration of antide and anti-FSH antibody to BDL rats decreased 1) ductal mass and 2) secretin-stimulated cAMP levels, proliferation, and ERK1/2 and Elk-1 phosphorylation in cholangiocytes compared with controls. In NRICC, FSH increased cholangiocyte proliferation, cAMP levels, and ERK1/2 and Elk-1 phosphorylation. The supernatant of cholangiocytes increased NRICC proliferation, inhibited by preincubation with anti-FSH antibody. Silencing of FSH gene decreases cholangiocyte proliferation and ERK1/2 and Elk-1 phosphorylation. Modulation of cholangiocyte FSH expression may be important for the management of cholangiopathies.


American Journal of Physiology-gastrointestinal and Liver Physiology | 2008

Progesterone stimulates the proliferation of female and male cholangiocytes via autocrine/paracrine mechanisms

Shannon Glaser; Sharon DeMorrow; Heather Francis; Yoshiyuki Ueno; Eugenio Gaudio; Shelley Vaculin; Julie Venter; Antonio Franchitto; Paolo Onori; Bradley Vaculin; Marco Marzioni; Candace Wise; Metaneeya Pilanthananond; Jennifer Savage; Lisa M. Pierce; Romina Mancinelli; Gianfranco Alpini

During cholestatic liver diseases, cholangiocytes express neuroendocrine phenotypes and respond to a number of hormones and neuropeptides by paracrine and autocrine mechanisms. We examined whether the neuroendocrine hormone progesterone is produced by and targeted to cholangiocytes, thereby regulating biliary proliferation during cholestasis. Nuclear (PR-A and PR-B) and membrane (PRGMC1, PRGMC2, and mPRalpha) progesterone receptor expression was evaluated in liver sections and cholangiocytes from normal and bile duct ligation (BDL) rats, and NRC cells (normal rat cholangiocyte line). In vivo, normal rats were chronically treated with progesterone for 1 wk, or immediately after BDL, rats were treated with a neutralizing progesterone antibody for 1 wk. Cholangiocyte growth was measured by evaluating the number of bile ducts in liver sections. The expression of the progesterone synthesis pathway was evaluated in liver sections, cholangiocytes and NRC. Progesterone secretion was evaluated in supernatants from normal and BDL cholangiocytes and NRC. In vitro, NRC were stimulated with progesterone and cholangiocyte supernatants in the presence or absence of antiprogesterone antibody. Aminoglutethimide was used to block progesterone synthesis. Cholangiocytes and NRC express the PR-B nuclear receptor and PRGMC1, PRGMC2, and mPRalpha. In vivo, progesterone increased the number of bile ducts of normal rats, whereas antiprogesterone antibody inhibited cholangiocyte growth stimulated by BDL. Normal and BDL cholangiocytes expressed the biosynthetic pathway for and secrete progesterone. In vitro, 1) progesterone increased NRC proliferation; 2) cholangiocyte supernatants increased NRC proliferation, which was partially inhibited by preincubation with antiprogesterone; and 3) inhibition of progesterone steroidogenesis prevented NRC proliferation. In conclusion, progesterone may be an important autocrine/paracrine regulator of cholangiocyte proliferation.


Gastroenterology | 2008

58 Evidence for a Novel Role for Histamine Regulation of Cholangiocarcinoma Growth By An Autocrine Mechanism

Heather Francis; Sharon DeMorrow; Julie Venter; Shelley Kopriva; Bradley Vaculin; Jennifer Savage; Gianfranco Alpini

correlated these data with the simultaneous presence of hepatitis B and C (HBV and HCV) infection.Methods: We quantified methylation levels at 19 CpG loci (HIC-1, CASP8, GSTP1, SOCS1, RASSF1A, p16, APC, CDH1, RUNX3, RIZ1, SFRP2, MINT31, COX2, MINT1, CACNA1G, RASSF2, MINT2, Reprimo, DCC) using combined bisulfite restriction analysis (COBRA). In total, 81 advanced tumors (well-differentiated HCCs >2 cm in size or moderately-poorly differentiated HCC), 12 early stage tumors (dysplastic nodules or well-differentiated HCC 2 cm size showing denser methylation compared with early tumors at these CpG loci. Additionally, HCV-related tumors tended to carry higher methylation levels at Group3 loci compared with HBV-related and virus-negative tumor, in both early and advanced tumors. Conclusions: Aberrant methylation is a frequent event in the liver and sequentially progresses from non-cancerous liver to early stage cancers and finally to advanced HCC. The cumulative differences in methylation levels among various liver tissues (precancerous livers, early and advanced tumors) suggest that aberrant methylation is an early event in HCC that progresses with the advancing stage. Lastly, simultaneous HCV infection may accelerate the carcinogenetic process in HCC.


Gastroenterology | 2008

S1590 Bile Acid Feeding Prevents Hepatic Artery Ligation-Induced Bile Duct Injury in Bile Duct Ligated Rats (BDL) By PI3K/AKT-Dependent Activation of Cholangiocyte VEGF-a Expression

Shannon Glaser; Eugenio Gaudio; Heather Francis; Yoshiyuki Ueno; Paolo Onori; Antonio Franchitto; Julie Venter; Domenico Alvaro; Bradley Vaculin; Shelley Kopriva; Jennifer Savage; Gianfranco Alpini


Archive | 2010

IP3/CaMK I/CREB pathway H1 histamine receptor stimulation by activation of the Small mouse cholangiocytes proliferate in response to

Jennifer Savage; Gianfranco Alpini; Shelley Vaculin; Bradley Vaculin; Khurshed A. Katki; Monique Stutes; Julie Venter; David E. Dostal; Paolo Onori; Antonio Franchitto; Shannon Glaser; Sharon DeMorrow; Eugenio Gaudio; Romina Mancinelli; Mellanie White; Fy Meng; Antonella Vetuschi; Roberta Sferra; G. Alpini; H Francis; P. Onori; A. Franchitto; J Venter; Shelley Kopriva; G Carpino


Gastroenterology | 2009

S1578 The Differential Effects of Histamine Receptor Subtypes On Cholangiocyte Proliferation of Normal Rats

Heather Francis; Sharon DeMorrow; Eugenio Gaudio; Yoshiyuki Ueno; Julie Venter; Paolo Onori; Antonio Franchitto; Guido Carpino; Marco Marzioni; Romina Mancinelli; Shannon Glaser; Shelley Kopriva; Ashley N. Kossie; Mellanie White; Jennifer Savage; Gianfranco Alpini


Gastroenterology | 2009

S1581 Stimulation of Biliary Proliferation By Follicle Stimulating Hormone (FSH) Is Mediated By Increased Expression of Nitric Oxide Synthase in Cholangiocytes

Romina Mancinelli; Paolo Onori; Eugenio Gaudio; Guido Carpino; Antonio Franchitto; Heather Francis; Cynthia J. Meininger; Sharon DeMorrow; Shannon Glaser; Julie Venter; Shelley Kopriva; Mellanie White; Ashley N. Kossie; Domenico Alvaro; Jennifer Savage; Gianfranco Alpini


Gastroenterology | 2009

S1580 PKCα Signaling Regulates the Inhibitory Effects of the H3 Histamine Receptor Agonist, RAMH, On Cholangiocarcinoma Growth

Heather Francis; Eugenio Gaudio; Julie Venter; Paolo Onori; Antonio Franchitto; Guido Carpino; Romina Mancinelli; Shelley Kopriva; Sharon DeMorrow; Jennifer Savage; Gianfranco Alpini

Collaboration


Dive into the Jennifer Savage's collaboration.

Top Co-Authors

Avatar

Antonio Franchitto

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Paolo Onori

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Romina Mancinelli

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Eugenio Gaudio

Sapienza University of Rome

View shared research outputs
Researchain Logo
Decentralizing Knowledge